Literature DB >> 26243184

An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.

Qiang Wu1, Yanyan Peng2, Xiaotao Zhao2.   

Abstract

Eight genome-wide association studies (GWASs) found that seven loci (rs2736100, rs4295627, rs4977756, rs498872, rs11979158, rs2252586, rs6010620) polymorphisms could elevate the risk of glioma, one of the most common types of primary brain cancer in adults. However, the replication studies about these seven loci obtained inconsistent results. In order to derive a more accurate estimation about the relationship between the selected single-nucleotide polymorphism (SNP) and susceptibility to glioma, we conducted a meta-analysis containing all eligible published case control studies to evaluate the association. An overall literature search was conducted using the database of PubMed, Science Direct, China national knowledge infrastructure (CNKI), and Embase. Seventeen articles with 25 studies were included in the meta-analysis. Glioma risk (odds ratio, OR; 95 % confidential interval, 95 %CI) was estimated with the random-effect model or the fixed-effects model. STATA 12.0 was applied to analyze all statistical data. Results showed that seven hot loci were all associated with increased risk of glioma (rs2736100, OR = 1.28, 95 %CI = 1.23-1.32; rs4295627, OR = 1.34, 95 %CI = 1.21-1.47; rs4977756, OR = 1.24, 95 %CI = 1.20-1.28; rs498872, OR = 1.24, 95 %CI = 1.15-1.33; rs6010620, OR = 1.29, 95 %CI = 1.24-1.35; rs11979158: OR = 1.18, 95 %CI = 1.10-1.25; rs2252586: OR = 1.18, 95 %CI = 1.10-1.25). Additionally, subgroup analysis by stages of glioma found that variation of rs11979158 had stronger relationship with high-grade (OR = 1.32, 95 %CI = 1.19-1.45) than low-grade glioma (OR = 1.12, 95 % CI = 1.03-1.21). Similarly, stratified analysis of rs2252586 by stages revealed the similar trend, with OR of 1.26 (95 %CI = 1.17-1.35) in high-grade glioma and OR of 1.15 (95 %CI = 1.08-1.22) in low-grade glioma. In summary, the present study showed that mutations of the seven loci could elevate the risk of glioma significantly. However, more other factors that could be related with glioma should be considered in further studies.

Entities:  

Keywords:  CCDC26; CDKN2A/B; EGFR; GWAS; Glioma; Meta-analysis; PHLDB1; RTEL1; Single-nucleotide polymorphism; TERT

Mesh:

Year:  2015        PMID: 26243184     DOI: 10.1007/s12035-015-9346-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  58 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Joint associations between genetic variants and reproductive factors in glioma risk among women.

Authors:  Sophia S Wang; Patricia Hartge; Meredith Yeager; Tania Carreón; Avima M Ruder; Martha Linet; Peter D Inskip; Amanda Black; Ann W Hsing; Michael Alavanja; Laura Beane-Freeman; Mahboobeh Safaiean; Stephen J Chanock; Preetha Rajaraman
Journal:  Am J Epidemiol       Date:  2011-09-13       Impact factor: 4.897

Review 3.  Genetic advances in glioma: susceptibility genes and networks.

Authors:  Yanhong Liu; Sanjay Shete; Fay Hosking; Lindsay Robertson; Richard Houlston; Melissa Bondy
Journal:  Curr Opin Genet Dev       Date:  2010-03-06       Impact factor: 5.578

4.  Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.

Authors:  Luo Wang; Qingyi Wei; Li-E Wang; Kenneth D Aldape; Yumei Cao; M Fatih Okcu; Kenneth R Hess; Randa El-Zein; Mark R Gilbert; Shiao Y Woo; Sujit S Prabhu; Greg N Fuller; Melissa L Bondy
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

5.  Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.

Authors:  Mahboobeh Safaeian; Preetha Rajaraman; Patricia Hartge; Meredith Yeager; Martha Linet; Mary Ann Butler; Avima M Ruder; Mark P Purdue; Ann Hsing; Laura Beane-Freeman; Jane A Hoppin; Demetrius Albanes; Stephanie J Weinstein; Peter D Inskip; Alina Brenner; Nathaniel Rothman; Nilanjan Chatterjee; Elizabeth M Gillanders; Stephen J Chanock; Sophia S Wang
Journal:  Cancer Causes Control       Date:  2013-08-01       Impact factor: 2.506

6.  Chromosome 7p11.2 (EGFR) variation influences glioma risk.

Authors:  Marc Sanson; Fay J Hosking; Sanjay Shete; Diana Zelenika; Sara E Dobbins; Yussanne Ma; Victor Enciso-Mora; Ahmed Idbaih; Jean-Yves Delattre; Khe Hoang-Xuan; Yannick Marie; Blandine Boisselier; Catherine Carpentier; Xiao-Wei Wang; Anna Luisa Di Stefano; Marianne Labussière; Konstantinos Gousias; Johannes Schramm; Anne Boland; Doris Lechner; Ivo Gut; Georgina Armstrong; Yanhong Liu; Robert Yu; Ching Lau; Maria Chiara Di Bernardo; Lindsay B Robertson; Kenneth Muir; Sarah Hepworth; Anthony Swerdlow; Minouk J Schoemaker; H-Erich Wichmann; Martina Müller; Stefan Schreiber; Andre Franke; Susanne Moebus; Lewin Eisele; Asta Försti; Kari Hemminki; Mark Lathrop; Melissa Bondy; Richard S Houlston; Matthias Simon
Journal:  Hum Mol Genet       Date:  2011-04-29       Impact factor: 6.150

7.  RTEL1 maintains genomic stability by suppressing homologous recombination.

Authors:  Louise J Barber; Jillian L Youds; Jordan D Ward; Michael J McIlwraith; Nigel J O'Neil; Mark I R Petalcorin; Julie S Martin; Spencer J Collis; Sharon B Cantor; Melissa Auclair; Heidi Tissenbaum; Stephen C West; Ann M Rose; Simon J Boulton
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

Review 8.  The 2007 WHO classification of tumors of the central nervous system - what has changed?

Authors:  Audrey Rousseau; Karima Mokhtari; Charles Duyckaerts
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

9.  Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis.

Authors:  Arabinda Das; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-08-13       Impact factor: 3.996

10.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

View more
  4 in total

1.  CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT.

Authors:  Ke Cao; Minhuan Li; Ji Miao; Xiaofeng Lu; Xing Kang; Hao Zhu; Shangce Du; Xue Li; Qian Zhang; Wenxian Guan; Ying Dong; Xuefeng Xia
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

2.  Epidermal Growth Factor Receptor (EGFR) Gene Polymorphism May be a Modifier for Cadmium Kidney Toxicity.

Authors:  Chun-Ting Lin; Ting-Hao Chen; Chen-Cheng Yang; Kuei-Hau Luo; Tzu-Hua Chen; Hung-Yi Chuang
Journal:  Genes (Basel)       Date:  2021-10-02       Impact factor: 4.096

3.  Burden and trends of brain and central nervous system cancer from 1990 to 2019 at the global, regional, and country levels.

Authors:  Yang Fan; Xian Zhang; Chao Gao; Shuai Jiang; Haoze Wu; Zhanhui Liu; Taotao Dou
Journal:  Arch Public Health       Date:  2022-09-17

4.  Associations between EGFR gene polymorphisms and susceptibility to glioma: a systematic review and meta-analysis from GWAS and case-control studies.

Authors:  Xiao Yu; Nian Rong Sun; Hai Tao Jang; Shi Wen Guo; Min Xue Lian
Journal:  Oncotarget       Date:  2017-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.